Littérature scientifique sur le sujet « Risk factors for HCC recurrence »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Risk factors for HCC recurrence ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Risk factors for HCC recurrence"
Ma, Hui, Zhongchen Li, Jia Yuan, Lan Zhang, Xiaoying Xie, Xin Yin, Rongxin Chen et Zhenggang Ren. « Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation ». Gastroenterology Research and Practice 2021 (2 janvier 2021) : 1–7. http://dx.doi.org/10.1155/2021/8878417.
Texte intégralZhu, Yu, Lingling Gu, Ting Chen, Guoqun Zheng, Chao Ye et Weidong Jia. « Factors influencing early recurrence of hepatocellular carcinoma after curative resection ». Journal of International Medical Research 48, no 8 (août 2020) : 030006052094555. http://dx.doi.org/10.1177/0300060520945552.
Texte intégralTsai, Yung-Fong, Fu-Chao Liu, Chun-Yu Chen, Jr-Rung Lin et Huang-Ping Yu. « Effect of Mycophenolate Mofetil Therapy on Recurrence of Hepatocellular Carcinoma after Liver Transplantation : A Population-Based Cohort Study ». Journal of Clinical Medicine 10, no 8 (7 avril 2021) : 1558. http://dx.doi.org/10.3390/jcm10081558.
Texte intégralGrasso, Alessandro, Alberto Quaglia, Paolo Montalto, Amar P. Dhillon, David Patch, Brian Davidson, Keith Rolles et al. « HCC and liver transplantation (LT) : risk factors for recurrence ». Journal of Hepatology 36 (avril 2002) : 80. http://dx.doi.org/10.1016/s0168-8278(02)80274-4.
Texte intégralHayashi, Michihiro, Tetsunosuke Shimizu, Fumitoshi Hirokawa, Yoshihiro Inoue, Koji Komeda, Mitsuhiro Asakuma, Yoshiharu Miyamoto, Atsushi Takeshita, Yuro Shibayama et Nobuhiko Tanigawa. « Clinicopathological Risk Factors for Recurrence within One Year after Initial Hepatectomy for Hepatocellular Carcinoma ». American Surgeon 77, no 5 (mai 2011) : 572–78. http://dx.doi.org/10.1177/000313481107700516.
Texte intégralTeng, Chiao-Fang, Tsai-Chung Li, Hsi-Yuan Huang, Wen-Ling Chan, Han-Chieh Wu, Woei-Cherng Shyu, Ih-Jen Su et Long-Bin Jeng. « Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection ». PLOS ONE 15, no 11 (25 novembre 2020) : e0242748. http://dx.doi.org/10.1371/journal.pone.0242748.
Texte intégralBürger, Christin, Miriam Maschmeier, Anna Hüsing-Kabar, Christian Wilms, Michael Köhler, Martina Schmidt, Hartmut H. Schmidt et Iyad Kabar. « Achieving Complete Remission of Hepatocellular Carcinoma : A Significant Predictor for Recurrence-Free Survival after Liver Transplantation ». Canadian Journal of Gastroenterology and Hepatology 2019 (8 janvier 2019) : 1–7. http://dx.doi.org/10.1155/2019/5796074.
Texte intégralYang, Jianming, Shijie Jiang, Yewu Chen, Jian Zhang et Yinan Deng. « Adjuvant ICIs Plus Targeted Therapies Reduce HCC Recurrence after Hepatectomy in Patients with High Risk of Recurrence ». Current Oncology 30, no 2 (31 janvier 2023) : 1708–19. http://dx.doi.org/10.3390/curroncol30020132.
Texte intégralYoshizumi, Tomoharu, Toru Ikegami, Shohei Yoshiya, Takashi Motomura, Yohei Mano, Jun Muto, Rumi Matono et al. « Impact of up-to-seven criteria and neutrophil-to-lymphocyte ratio in liver transplantation for patients who received pretreatment for hepatocellular carcinoma. » Journal of Clinical Oncology 30, no 15_suppl (20 mai 2012) : e14536-e14536. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e14536.
Texte intégralCho, Wei-Ru, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin et al. « Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients ». PLOS ONE 16, no 3 (4 mars 2021) : e0247231. http://dx.doi.org/10.1371/journal.pone.0247231.
Texte intégralThèses sur le sujet "Risk factors for HCC recurrence"
Costa, Paulo Everton Garcia. « Risk factors for hepatocellular carcinoma recurrence after liver transplantation ». Universidade Federal do CearÃ, 2014. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11640.
Texte intégralO carcinoma hepatocelular (CHC) à o mais frequente tumor primÃrio maligno do fÃgado, com incidÃncia mundial anual de mais de um milhÃo de casos, sendo responsÃvel por pelo menos 500.000 mortes por ano. Em torno de 90 % a 95 % dos tumores estÃo associados à cirrose. O transplante hepÃtico (TH) à uma modalidade de tratamento curativo para o CHC. Entretanto, a recorrÃncia do CHC apÃs o TH à o principal obstÃculo ao sucesso deste tratamento. O objetivo deste estudo foi avaliar os fatores de risco para recorrÃncia de carcinoma hepatocelular apÃs a realizaÃÃo de TH. Foram realizados 664 transplantes de fÃgado entre maio de 2002 e abril de 2012, no Hospital UniversitÃrio Walter CantÃdio, da Universidade Federal do Cearà (HUWC â UFC), dos quais 140 casos em pacientes com diagnÃstico de CHC. Foi realizado um estudo analÃtico, descritivo, retrospectivo e longitudinal deste grupo de pacientes, analisando os fatores de risco para a recorrÃncia de CHC apÃs o TH. As variÃveis analisadas foram: sexo, idade, tipo sanguÃneo, etiologia da cirrose, nÃvel de alfa-fetoproteÃna, mÃtodos diagnÃsticos de imagem, critÃrios de MilÃo, tempo entre o diagnÃstico do CHC e a realizaÃÃo do TH, tempo em lista de espera para o TH e caracterÃsticas anatomopatolÃgicas do tumor no explante. O CHC foi mais frequente em homens com idade mÃdia de 56 anos, infectados pelo vÃrus da hepatite C. A taxa de recorrÃncia do carcinoma hepatocelular apÃs o transplante de fÃgado foi de 8,57% e ocorreu mais frequentemente nos dois primeiros anos apÃs o transplante, tendo como local mais comum o enxerto hepÃtico. Concluiu-se que o tempo de permanÃncia em lista de transplante acima de 7,8 meses, a presenÃa de mais de 3,5 nÃdulos no explante, o tumor excedendo os critÃrios de MilÃo, o nÃvel de Alfa-fetoproteÃna acima de 1000 ng/ml e a presenÃa de invasÃo microvascular sÃo fatores de risco independentes para recorrÃncia de carcinoma hepatocelular apÃs a realizaÃÃo do transplante hepÃtico.
Knut, R. P. « Groin hernia : anatomically determined risk factors for the recurrence ». Thesis, БДМУ, 2022. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/19674.
Texte intégralDalberg, Kristina. « Risk factors for ipsilateral breast tumor recurrence and uncontrolled local disease / ». Stockholm, 1998. http://diss.kib.ki.se/search/diss.se.cfm?19981016dalb.
Texte intégralWest, Emily S. « Risk factors for trichiasis recurrence in a trachoma-endemic area of central Tanzania ». Available to US Hopkins community, 2002. http://wwwlib.umi.com/dissertations/dlnow/3068228.
Texte intégralDeshpande, Abhishek, Vinay Pasupuleti, Priyaleela Thota, Chaitanya Pant, David D. K. Rolston, Adrian V. Hernandez, Curtis J. Donskey et Thomas G. Fraser. « Risk factors for recurrent Clostridium difficile infection : a systematic review and meta-analysis ». Cambridge University Press, 2015. http://hdl.handle.net/10757/608263.
Texte intégralOBJECTIVE: An estimated 20-30% of patients with primary Clostridium difficile infection (CDI) develop recurrent CDI (rCDI) within 2 weeks of completion of therapy. While the actual mechanism of recurrence remains unknown, a variety of risk factors have been suggested and studied. The aim of this systematic review and meta-analysis was to evaluate current evidence on the risk factors for rCDI. DESIGN: We searched MEDLINE and 5 other databases for subject headings and text related to rCDI. All studies investigating risk factors of rCDI in a multivariate model were eligible. Information on study design, patient population, and assessed risk factors were collected. Data were combined using a random-effects model and pooled relative risk ratios (RRs) were calculated. RESULTS: A total of 33 studies (n=18,530) met the inclusion criteria. The most frequent independent risk factors associated with rCDI were age≥65 years (risk ratio [RR], 1.63; 95% confidence interval [CI], 1.24-2.14; P=.0005), additional antibiotics during follow-up (RR, 1.76; 95% CI, 1.52-2.05; P<.00001), use of proton-pump inhibitors (PPIs) (RR, 1.58; 95% CI, 1.13-2.21; P=.008), and renal insufficiency (RR, 1.59; 95% CI, 1.14-2.23; P=.007). The risk was also greater in patients previously on fluoroquinolones (RR, 1.42; 95% CI, 1.28-1.57; P<.00001). CONCLUSIONS: Multiple risk factors are associated with the development of rCDI. Identification of modifiable risk factors and judicious use of antibiotics and PPI can play an important role in the prevention of rCDI.
DeFeo, Graig Charles. « Risk Factors for Recurrent Major Depressive Disorder in a Nationally Representative Sample ». Scholar Commons, 2014. https://scholarcommons.usf.edu/etd/5351.
Texte intégralPennlert, Johanna. « Recurrent stroke : risk factors, predictors and prognosis ». Doctoral thesis, Umeå universitet, Medicin, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-127304.
Texte intégralAbraham, Elizabeth C. M. D. « Focal Segmental Glomerulosclerosis in Children : An Emerging Epidemic and Risk Factors for Disease Recurrence in Transplants ». University of Cincinnati / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1320172013.
Texte intégralNatalucci, Valentina. « Effect of exercise in Breast Cancer and its association with tumor characteristics, risk factors for recurrence and lifestyle ». Doctoral thesis, Urbino, 2018. http://hdl.handle.net/11576/2663506.
Texte intégralLouzada, Martha. « Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy ». Thesis, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/19827.
Texte intégralLivres sur le sujet "Risk factors for HCC recurrence"
Paula, Wells, et Halstead Regina, dir. Rectal cancer : Etiology, pathogenesis and treatment. Hauppauge, NY : Nova Science Publishers, 2009.
Trouver le texte intégralBagrodia, Aditya, et Yair Lotan. Low and intermediate risk non-muscle-invasive bladder cancer. Sous la direction de James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0076.
Texte intégralBamia, Christina, Sherri Stuver et Lorelei Mucci. Cancer of the Liver and Biliary Tract. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0012.
Texte intégralThomas London, W., Jessica L. Petrick et Katherine A. McGlynn. Liver Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0033.
Texte intégralKeshav, Satish, et Palak Trivedi. Liver cancer. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0218.
Texte intégralIqbal, Muhammad Waqas, Michael E. Lipkin et Glenn M. Preminger. Prevention of other non-calcium stones. Sous la direction de John Reynard. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0016.
Texte intégralIqbal, Muhammad Waqas, Ghalib Jibara, Michael E. Lipkin et Glenn M. Preminger. Evaluation of stone formers. Sous la direction de John Reynard. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0014.
Texte intégralTaylor, Eric N., et Gary C. Curhan. Epidemiology of nephrolithiasis. Sous la direction de Mark E. De Broe. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0199.
Texte intégralTurney, Ben, et John Reynard. Kidney stones. Sous la direction de John Reynard. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0013.
Texte intégralTurney, Ben, et John Reynard. Epidemiology of stone disease. Sous la direction de John Reynard. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0012.
Texte intégralChapitres de livres sur le sujet "Risk factors for HCC recurrence"
Ouchi, Kiyoaki, Shuji Matsubara, Kenji Fukuhara et Seiki Matsuno. « Factors Affecting Long-Term Survival and Recurrence of Hepatocellular Carcinoma (HCC) After Hepatic Resection ». Dans Recent Advances in Management of Digestive Cancers, 637–39. Tokyo : Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68252-3_188.
Texte intégralNault, Jean-Charles, et Jessica Zucman-Rossi. « Genomic Signatures of Risk Factors and Molecular Identification of HCC Subtypes ». Dans Hepatocellular Carcinoma, 113–19. Cham : Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-34214-6_6.
Texte intégralRouvier, Pierre, et Roger Peynegre. « Recurrence of Polyposis : Risk Factors, Prevention, Treatment and Follow-Up ». Dans Micro-endoscopic Surgery of the Paranasal Sinuses and the Skull Base, 287–307. Berlin, Heidelberg : Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-57153-4_22.
Texte intégralVan Nuffel, Maarten, et Ilse Degreef. « Is Recurrence After Treatment Predictable ? Risk Factors in Dupuytren Disease ». Dans Dupuytren Disease and Related Diseases - The Cutting Edge, 291–97. Cham : Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32199-8_39.
Texte intégralSalazar, Javier, et Anne Le. « The Heterogeneity of Liver Cancer Metabolism ». Dans The Heterogeneity of Cancer Metabolism, 127–36. Cham : Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_9.
Texte intégralAmbrosone, Christine B., Chi-Chen Hong et Pamela J. Goodwin. « Host Factors and Risk of Breast Cancer Recurrence : Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes ». Dans Improving Outcomes for Breast Cancer Survivors, 143–53. Cham : Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-16366-6_10.
Texte intégralLim, Joon Seok, Honsoul Kim et Nieun Seo. « Risk Factors for Recurrence and Tumor Response Evaluation After Neoadjuvant Therapy-Based Radiological Study ». Dans Surgical Treatment of Colorectal Cancer, 63–73. Singapore : Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-5143-2_7.
Texte intégralSarig, S., R. Azoury et S. Perlberg. « Use of Risk Factors in Medical Management to Reduce Recurrence of Calcium-Oxalate Kidney Stones ». Dans Urolithiasis, 837. Boston, MA : Springer US, 1989. http://dx.doi.org/10.1007/978-1-4899-0873-5_265.
Texte intégralHan, Kwang-Hyub, Jeong Il Jeong, Sang Hoon Ahn, Dong Kee Kim, Chae Yoon Chon et Young Myoung Moon. « The Efficacy of the Ultrasonographic Screening Test for Early Detection of Hepatocellular Carcinoma and Risk Factors of HCC in Korea ». Dans Progress in Hepatocellular Carcinoma Treatment, 1–9. Tokyo : Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-67913-4_1.
Texte intégralBalmes, J. L. « After interruption of the treatment, is the risk of recurrence elevated, and what other factors could be implicated in the determinism of reflux to avoid an indefinite intake of antacids ? » Dans Benign Lesions of the Esophagus and Cancer, 330–33. Berlin, Heidelberg : Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-73055-9_91.
Texte intégralActes de conférences sur le sujet "Risk factors for HCC recurrence"
Thu Huyen, Nguyen Thi, Mai Hong Bang, Tran Van Riep et Nguyen Tien Thinh. « IDDF2018-ABS-0080 Risk factors for local recurrence in the treatment of radiofrequency ablation with cool-tip electrode for HCC patients ». Dans International Digestive Disease Forum (IDDF) 2018, Hong Kong, 9–10 June 2018. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2018. http://dx.doi.org/10.1136/gutjnl-2018-iddfabstracts.203.
Texte intégralShostak, E., R. Liberman et D. Riker. « Stage I NSCLC : Risk Factors for Recurrence. » Dans American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1107.
Texte intégralKrambeck, Amy E., Laureano J. Rangel, Andrew J. LeRoy, David E. Patterson, Matthew T. Gettman, James C. Williams, Andrew P. Evan, James E. Lingeman et James A. McAteer. « Risk Factors for Stone Recurrence after Percutaneous Nephrolithotomy ». Dans RENAL STONE DISEASE 2 : 2nd International Urolithiasis Research Symposium. AIP, 2008. http://dx.doi.org/10.1063/1.2998038.
Texte intégralHamao, Nobuyoshi, Isao Ito, Naoya Tanabe, Satoshi Konishi, Masahiro Shirata, Issei Oi, Seiichiro Imai, Hisako Matsumoto et Toyohiro Hirai. « Risk factors for recurrence of fever in aspiration pneumonia ». Dans ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2024.
Texte intégralUeno, A., M. Hirata, Y. Yamamura, K. Fujita, N. Shibutou et M. Yamamura. « AB0646 Identification of risk factors for recurrence in polymyalgia rheumatica ». Dans Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.7128.
Texte intégralMizumori, Yasuyuki, Nobuya Hirata, Ryota Hiraoka, Katsuya Hirano, Ryota Kominami, Sayaka Takahashi, Yasushi Fukuda et al. « Preoperative biopsy risk for recurrence ? : A retrospective study of risk factors for recurrence of stage 1A non-small cell lung cancer ». Dans ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa3775.
Texte intégralKim, HJ, et JS Kim. « RISK FACTORS FOR RECURRENCE OF STONE AFTER COMMON BILE DUCT STONES REMOVAL ». Dans ESGE Days. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1704965.
Texte intégralErol, Serhat, Aslihan Gurun, Fatma Ciftci, Aydin Ciledag, Akin Kaya, Elif Sen, Gokhan Celik et Ismail Savas. « Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence ». Dans ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2493.
Texte intégralHwang, In Sun, Chaewon Kim, Keun Ho Lee et Jigeun Yoo. « 2022-RA-197-ESGO Risk factors and patterns of recurrence in patients with low-risk endometrial cancer ». Dans ESGO 2022 Congress. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-esgo.205.
Texte intégralSpagnol, G., I. Pezzani, G. Corrao, S. Gava, V. Bernardini, S. Kilzie, G. Artioli et al. « 230 The role of prognostic risk factors in endometrial cancer recurrence : a retrospective study ». Dans ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.127.
Texte intégralRapports d'organisations sur le sujet "Risk factors for HCC recurrence"
Qian, Ao, Xin Zhang, Gang Huo, Jiaojiao Yu et Xiaoshu Wang. Risk factors of recurrence in Rathke cleft cyst : a systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, octobre 2021. http://dx.doi.org/10.37766/inplasy2021.10.0070.
Texte intégralGuo, Zhiyi, Kejia Yang, Jing Lei, Yongjian Zeng, Zhidong Guo et Fenghua Zhang. Risk factors for recurrence of tic disorders in children:a systematic review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, février 2022. http://dx.doi.org/10.37766/inplasy2022.2.0078.
Texte intégralHubsky, Ashlee. Hepatocellular Carcinoma Recurrence After Liver Transplantation : An Analysis of Risk Factors and Incidence from Oregon Health Science University. Portland State University Library, janvier 2016. http://dx.doi.org/10.15760/honors.213.
Texte intégralShumway, Dean A., Kimberly S. Corbin, Magdoleen H. Farah, Kelly E. Viola, Tarek Nayfeh, Samer Saadi, Vishal Shah et al. Partial Breast Irradiation for Breast Cancer. Agency for Healthcare Research and Quality (AHRQ), janvier 2023. http://dx.doi.org/10.23970/ahrqepccer259.
Texte intégral